These behavioral changes were associated with alterations in the GABA system of the brain in the probiotic group, matching the known effects of antidepressant or
anxiolytic chemical agents (for example, anxiolytic agents such as benzodiazepines work at GABA receptors)[91].
For 20 years, he has worked with the legal community evaluating product safety and defending products such as welding rods, cellular telephones, breast implants, wound care products, dietary supplements, general healthcare products,
chemical exposures (e.g., hydraulic fracturing components), and a host of pharmaceutical
agents (including antidepressants, dermatologics, anti-malarials,
anxiolytics, antipsychotics, and diet drugs).